Additional Proxy Soliciting Materials (definitive) (defa14a)
April 29 2020 - 04:23PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934 (Amendment No.
)
|
|
|
|
Filed by
the Registrant ☒
|
|
Filed by
a Party other than the Registrant ☐
|
|
Check the
appropriate box:
|
☐
|
Preliminary
Proxy Statement
|
☐
|
Confidential, for Use of the Commission Only (as permitted by Rule
14a-6(e)(2))
|
☐
|
Definitive
Proxy Statement
|
☒
|
Definitive
Additional Materials
|
☐
|
Soliciting
Material under §240.14a-12
|
|
Entasis
Therapeutics Holdings Inc.
|
(Name of
Registrant as Specified In Its Charter)
|
|
|
(Name of
Person(s) Filing Proxy Statement, if other than the
Registrant)
|
|
Payment
of Filing Fee (Check the appropriate box):
|
☒
|
No fee
required.
|
☐
|
Fee
computed on table below per Exchange Act Rules 14a-6(i)(1) and
0-11.
|
|
(1)
|
Title of
each class of securities to which transaction applies:
|
|
|
|
|
(2)
|
Aggregate
number of securities to which transaction applies:
|
|
|
|
|
(3)
|
Per unit
price or other underlying value of transaction computed pursuant to
Exchange Act Rule 0-11 (set forth the amount on which the filing
fee is calculated and state how it was determined):
|
|
|
|
|
(4)
|
Proposed
maximum aggregate value of transaction:
|
|
|
|
|
(5)
|
Total fee
paid:
|
|
|
|
☐
|
Fee paid
previously with preliminary materials.
|
☐
|
Check box
if any part of the fee is offset as provided by Exchange Act Rule
0-11(a)(2) and identify the filing for which the offsetting fee was
paid previously. Identify the previous filing by registration
statement number, or the Form or Schedule and the date of its
filing.
|
|
(1)
|
Amount
Previously Paid:
|
|
|
|
|
(2)
|
Form,
Schedule or Registration Statement No.:
|
|
|
|
|
(3)
|
Filing
Party:
|
|
|
|
|
(4)
|
Date
Filed:
|
|
|
|
|
|
|
|

|
MMMMMMMMMMMM + MMMMMMM C 1234567890 The Sample Company 000004
ENDORSEMENT_LINE______________ SACKPACK_____________ MR A SAMPLE
DESIGNATION (IF ANY) ADD 1 ADD 2 ADD 3 ADD 4 ADD 5 ADD 6 Online Go
to www.envisionreports.com/ETTX or scan the QR code — login details
are located in the shaded bar below. Important Notice Regarding the
Availability of Proxy Materials for the Entasis Therapeutics
Holdings Inc. Stockholder Meeting to be Held on June 10, 2020 Under
Securities and Exchange Commission rules, you are receiving this
notice that the proxy materials for the annual stockholders’
meeting are available on the Internet. Follow the instructions
below to view the materials and vote online or request a copy. The
items to be voted on and location of the annual meeting are on the
reverse side. Your vote is important! This communication presents
only an overview of the more complete proxy materials that are
available to you on the Internet. We encourage you to access and
review all of the important information contained in the proxy
materials before voting. The 2019 Annual Report on Form 10-K and
2020 proxy statement to stockholders are available at:
www.envisionreports.com/ETTX Easy Online Access — View your proxy
materials and vote. Step 1: Step 2: Step 3: Step 4: Step 5: Go to
www.envisionreports.com/ETTX. Click on Cast Your Vote or Request
Materials. Follow the instructions on the screen to log in. Make
your selections as instructed on each screen for your delivery
preferences. Vote your shares. When you go online, you can also
help the environment by consenting to receive electronic delivery
of future materials. Obtaining a Copy of the Proxy Materials – If
you want to receive a copy of the proxy materials, you must request
one. There is no charge to you for requesting a copy. Please make
your request as instructed on the reverse side on or before May 29,
2020 to facilitate timely delivery. + 2 N O T C O Y 038K6D
MMMMMMMMM Stockholder Meeting Notice 1234 5678 9012 345
|

|
Entasis Therapeutics Holdings Inc. Annual Meeting of Stockholders
will be held on Wednesday, June 10, 2020, 9:30 a.m. Local Time, via
the internet at www.meetingcenter.io/259547029. The password for
this meeting is — ETTX2020. Proposals to be voted on at the meeting
are listed below along with the Board of Directors’
recommendations. The Board of Directors recommend a vote FOR the
nominees listed and FOR Proposals 2 and 3: 1. 2. 3. Election of
Directors. Ratification of the selection of the independent
registered public accounting firm. Approval of amendment of 2018
Equity Incentive Plan. PLEASE NOTE – YOU CANNOT VOTE BY RETURNING
THIS NOTICE. To vote your shares you must go online or request a
paper copy of the proxy materials to receive a proxy card. Here’s
how to order a copy of the proxy materials and select delivery
preferences: Current and future delivery requests can be submitted
using the options below. If you request an email copy, you will
receive an email with a link to the current meeting materials.
PLEASE NOTE: You must use the number in the shaded bar on the
reverse side when requesting a copy of the proxy materials. — — —
Internet – Go to www.envisionreports.com/ETTX. Click Cast Your Vote
or Request Materials. Phone – Call us free of charge at
1-866-641-4276. Email – Send an email to
investorvote@computershare.com with “Proxy Materials Entasis
Therapeutics Holdings Inc.” in the subject line. Include your full
name and address, plus the number located in the shaded bar on the
reverse side, and state that you want a paper copy of the meeting
materials. To facilitate timely delivery, all requests for a paper
copy of proxy materials must be received by May 29, 2020.
Stockholder Meeting Notice
|
Entasis Therapeutics (NASDAQ:ETTX)
Historical Stock Chart
From Dec 2020 to Jan 2021
Entasis Therapeutics (NASDAQ:ETTX)
Historical Stock Chart
From Jan 2020 to Jan 2021